ME 23andMe Inc. Quarterly EPS earnings growth

Corporate emblem and logo of 23andMe Holding Co. (ME)

23andMe Holding Co. has established a global network of genomic profiles, becoming a valuable partner for pharmaceutical developers. Business revenues are based on the sale of DNA kits and paid subscriptions for medical advice. The quarterly EPS change reflects profit dynamics, where the indicator value reaches 81.80. The massive archive of biodata forms a powerful defensive barrier, despite strict privacy controls.

23andme.com (ME) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 04/05/2025

Analytical breakdowns and data insights for company 23andMe Holding Co. (ME)

- market value and analyst target forecast:
Comprehensive company analysis:23andMe Inc., ME
Manufactured product of 23andMe Inc

Quarterly earnings per share (EPS) growth measures the trend of net income per share, determining the fundamental stability and margin of safety of a business for the long-term investor. By analyzing the quarterly EPS change, one can see how the critical liquidity deficit of 23andMe Holding Co. (ME) and the shift in its business model impact the company's ability to generate real income.

Who 23andMe Holding Co. competes with

A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|FLGT (fulgentgenetics.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Standard BioTools Corp|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Biosciences, Inc.)|OSUR (OraSure Technologies) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth XGN (exagen.com)|MDxHealth Inc. - Year-over-year earnings per share growth for the last twelve months|Lucid Diagnostics, Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Prenetics Global Limited PRE|Insight Molecular (IMDX) - Year-over-year earnings per share growth for the last twelve months|TRIB (Trinity Biotech PLC) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months ProPhase Labs|Ainos (AIMD) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Biomerica BMRA|CDIO: Year-over-year earnings per share growth for the last 12 months|Onconetix Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Year-over-year earnings per share growth for the last twelve months|Vermillion - Year-over-year earnings per one share growth for the last 12 months|AXDX (Accelerate Diagnostics Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months CENTOGENE, N.V. (CNTG)|Year-over-year net earnings per share growth for the last 12 months ENZ (Enzo)|Quarterly EPS earnings growth Fresh2 Group Limited (FRES)|Quarterly EPS earnings growth GENE (GTG Labs)|PMD: Year-over-year earnings per share growth for the last 12 months